Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger CCCH-type containing 11B (ZC3H11B) is a protein-coding gene predicted to enable metal ion binding and is involved in the export of poly(A)+ mRNA from the nucleus, suggesting a role in post-transcriptional gene regulation[2][5]. ZC3H11B is structurally related to other zinc finger proteins, which serve as transcription factors or RNA-binding proteins influencing gene expression and numerous cellular processes[1][4]. Genetic studies have identified variants in ZC3H11B associated with ocular axial length and the risk and severity of myopia, indicating its relevance in eye growth and possibly in refractive error syndromes[2][5]. No evidence currently defines ZC3H11B as a direct therapeutic target or druggable protein, nor are there known small-molecule drugs or biologics targeting this gene[2][5]. Its most recognized implication is as a genetic biomarker for myopia susceptibility and progression[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger CCCH-type containing 11B (ZC3H11B).